| Literature DB >> 26350958 |
Chunhua Zhou1,2, Weizhi Wang1, Jiwei Wang1, Xiaoyu Zhang1,3, Qun Zhang1, Bowen Li1, Zekuan Xu1,4.
Abstract
Laparoscopic repair (LR) for perforated peptic ulcer (PPU) has been introduced since 1990. Although many studies comparing LR with open repair (OR) have been published, controversy remains regarding the clinical utility of laparoscopic techniques for the treatment of PPU. Thus, it is necessary for us to broaden our knowledge on this subject with the newly published articles. Twenty-four nonrandomized controlled studies (NRS) and five randomized controlled trails (RCTs) were included in our meta-analyses, which comprised 5,268 patients (1,890 in the LR group and 3,378 in the OR group). In the analysis of high quality NRS and RCTs, compared with OR, high quality evidence suggested that LR was associated with a lower incidence of overall postoperative complications; moderate evidence showed that the two procedures had the similar reoperation rate; based on the low quality evidence, LR had reduced hospital mortality and similar operative time; Moreover, LR was observed having the advantages of earlier resumption of oral intake, shorter hospital stay and less analgesic use, which were supported by very low evidence. All the evidences suggest that LR is better than OR for PPU, but more high-quality RCTs are still needed for further validation.Entities:
Mesh:
Year: 2015 PMID: 26350958 PMCID: PMC4563564 DOI: 10.1038/srep13976
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Quality assessment of the nonrandomized studies base on the Newcastle-Ottawa quality assessment scale.
| References | score | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Matsuda | * | * | * | * | 4 | ||||
| Johansson | * | * | * | * | * | 5 | |||
| Miserez | * | * | * | * | ** | * | 7 | ||
| So | * | * | * | * | ** | * | * | * | 9 |
| Bergamaschi | * | * | * | * | * | * | * | * | 8 |
| Naesgaard | * | * | * | * | ** | * | 7 | ||
| Katkhouda | * | * | * | * | ** | * | * | * | 9 |
| Kok | * | * | * | * | * | * | 6 | ||
| Robertson | * | * | * | * | ** | * | * | * | 9 |
| Michelet | * | * | * | * | * | 5 | |||
| Lee | * | * | * | * | * | 5 | |||
| Mehendale | * | * | * | * | * | * | 6 | ||
| Seelig | * | * | * | * | ** | * | 7 | ||
| Malkov | * | * | * | ** | * | * | * | 8 | |
| Krishtein | * | * | * | * | ** | * | 7 | ||
| Vettoretto | * | * | * | * | ** | * | 7 | ||
| Lunevicius | * | * | * | * | * | * | 6 | ||
| Ates | * | * | * | * | ** | * | * | * | 9 |
| Golash | * | * | * | * | ** | * | 7 | ||
| Bhogal | * | * | * | * | ** | * | 7 | ||
| Thorsen | * | * | * | * | ** | * | 7 | ||
| Kuwabara | * | * | * | * | * | * | 6 | ||
| Critchley | * | * | * | * | ** | * | 7 | ||
| Dominguez-Vega | * | * | * | * | * | * | 6 | ||
1age and sex.
2ASA, American Society of Anesthesiology classification.
3duration of perforation.
4MPI, Mannheim Peritonitis-Index to score peritonitis.
Quality assessment of the randomized controlled studies based on the Cochrane Risk of Bias Tool.
| Lau | 1996 | + | + | ? | − | + | + |
| Lau | 1998 | + | ? | ? | ? | + | + |
| Siu | 2002 | + | + | − | + | + | + |
| Bertleff | 2009 | + | + | − | + | + | + |
| Schietroma | 2013 | + | + | ? | + | + | + |
+: Low risk of bias?: Unclear −: High risk of bias.
Details of the articles included in the meta-analysis.
| References | Year | Country | Journal | Type of the study | ||
|---|---|---|---|---|---|---|
| Matsuda | 1995 | Japan | Annal Surg | 11 | 4 | Retrospective Cohort study |
| Johansson | 1996 | Sweden | Surg Endosc | 10 | 17 | Retrospective Cohort study |
| Miserez | 1996 | Germany | Surg Endosc | 18 | 16 | Retrospective Cohort study |
| So | 1996 | Singapore | Surg Endosc | 15 | 38 | Retrospective Cohort study |
| Bergamaschi | 1999 | Norway | Surg Endosc | 17 | 62 | Prospective Cohort study |
| Naesgaard | 1999 | Norway | Eur J Surg | 25 | 49 | Retrospective Cohort study |
| Katkhouda | 1999 | America | Arch Surg | 30 | 16 | Prospective Cohort study |
| Kok | 1999 | Brunei | AM J Surg | 11 | 20 | Retrospective Cohort study |
| Robertson | 2000 | UK&Australia | Ann R Coll Surg | 20 | 16 | Prospective Cohort study |
| Michelet | 2000 | Italy | Eur J Surg | 16 | 14 | Retrospective Cohort study |
| Lee | 2001 | China | Br J Surg | 155 | 219 | Prospective Cohort study |
| Mehendale | 2002 | India | Indian J Gastroenterol | 34 | 33 | Prospective Cohort study |
| Seelig | 2003 | Germany | J Clin gastroenterology | 24 | 31 | Retrospective Cohort study |
| Malkov | 2004 | Azerbaijan | J AM COLL | 42 | 40 | Retrospective Cohort study |
| Krishtein | 2005 | Israel | Surg Endosc | 68 | 66 | Retrospective Cohort study |
| Vettoretto | 2005 | Italy | CHIRURGIA ITALIANA | 10 | 10 | Retrospective Cohort study |
| Lunevicius | 2005 | Lithuania | Surg Endosc | 60 | 162 | Retrospective Cohort study |
| Ates | 2007 | Turkey | J LAPAROENDOSC ADV A | 17 | 18 | Prospective Cohort study |
| Golash | 2008 | Oman | Omen medical J | 95 | 57 | Retrospective Cohort study |
| Bhogal | 2008 | UK | World J Surg | 19 | 14 | Prospective Cohort study |
| Thorsen | 2011 | Norway | J Gastrointest Surg | 36 | 66 | Retrospective Cohort study |
| Kuwabara | 2011 | Japan | World J Surg | 836 | 2073 | Retrospective Cohort study |
| Critchley | 2011 | UK | Ann R Coll Surg | 53 | 89 | Prospective Cohort study |
| Dominguez-Vega | 2013 | Spain | CIR ESP | 60 | 52 | Retrospective Cohort study |
| Lau | 1996 | China | Annal Surg | 24 | 21 | Randomized controlled trail |
| Lau | 1998 | China | AM J Surg | 12 | 10 | Randomized controlled trail |
| Siu | 2002 | China | Annal Surg | 63 | 58 | Randomized controlled trail |
| Bertleff | 2009 | Netherlands | World J Surg | 52 | 49 | Randomized controlled trail |
| Scheietroma | 2013 | Italy | J INVEST SURG | 57 | 58 | Randomized controlled trail |
LR, laparoscopic repair; OR, open repair
Figure 1Articles identified with criteria for inclusion and exclusion.
Figure 2Analysis of high quality NRS comparing (A) operative time, (B) first oral intake, (C) postoperative hospital stay, (D) reoperation rate, (E) postoperative complications, (F) hospital mortality.
Overall results comparing LR with OR.
| Items | Type | na | WMD or RR 95% CI | ||||
|---|---|---|---|---|---|---|---|
| Operative time | NRS | 12 | 11.77 (1.75, 21.79) | 2.30 | 97.5% | ||
| RCT | 3 | 7.61 (−11.93, 27.15) | 0.76 | 0.445 | 90.5% | ||
| First oral intake day | NRS | 6 | −1.34 (−2.12, −0.55) | 3.34 | 96.3% | ||
| RCT | 2 | −0.27(−1.51, 0.97) | 0.42 | 0.672 | <0.1% | 0.483 | |
| Postoperative hospitalization | NRS | 10 | −2.83 (−3.86, −1.80) | 5.37 | 92.9% | ||
| RCT | 3 | −2.36 (−6.47, 1.74) | 1.13 | 0.259 | 91.1% | ||
| Reoperation rate | NRS | 5 | 0.70 (0.30, 1.64) | 0.82 | 0.412 | 27.4% | 0.239 |
| RCT | 2 | 2.11 (0.50, 8.97) | 1.01 | 0.313 | 53.4% | 0.143 | |
| Postoperative complications | NRS | 13 | 0.49 (0.27, 0.88) | 2.37 | 68.0% | ||
| RCT | 4 | 0.48 (0.36, 0.65) | 4.82 | <0.1% | 0.596 | ||
| Hospital mortality | NRS | 15 | 0.63 (0.41, 0.98) | 2.07 | <0.1% | 0.844 | |
| RCT | 3 | 0.39 (0.17, 1.32) | 1.51 | 0.131 | <0.1% | 0.951 | |
| Analgesic injection (days) | NRS | 3 | −3.60 (−5.50, −1.70) | 3.70 | 98.2% | ||
| RCT | 3 | −2.74 (−5.62, 0.15) | 1.86 | 0.063 | 93.3% | ||
| Analgesic injection (mg) | NRS | 3 | −106.59 (−124.01, −89.17) | 11.99 | 23.4% | 0.271 | |
CI, confidence interval; LR, laparoscopic repair; OR, open repair; RR, relative risks; WMD, weighed mean difference; NRS, non-randomized studies; RCT, randomzed controlled trails; data in bold, significant P-value.
aNumber of comparisons.
bHigh quality NRS (≥7 scores).
Analysis of postoperative complications comparing LR with OR by categories.
| Surgical complications* | Type | na | RR 95% CI | ||||
|---|---|---|---|---|---|---|---|
| Major | NRS | 7 | 0.62 (0.31, 1.24) | 1.34 | 0.181 | <0.1% | 0.689 |
| RCT | 4 | 0.69 (0.28, 1.71) | 0.80 | 0.422 | 22.0% | 0.279 | |
| Minor | NRS | 13 | 0.43 (0.18, 1.06) | 1.84 | 0.066 | 68.3% | |
| RCT | 4 | 0.45 (0.30, 0.67) | 3.94 | <0.1% | 0.672 | ||
CI, confidence interval; LR, laparoscopic repair; OR, open repair; RR, relative risks; NRS, non-randomized studies; RCT, randomzed controlled trails; data in bold, significant P-value.
*Definitions: mjor surgical complications: anastomotic leak or fistula, complications that required reoperation or resulted in hospital death and all intra-abdominal collections; minor surgical complications: wound complications, any bleeding event, pancreatitis, pneumonia, urinary tract infection, burst abdomen, ileus, gastric emptying difficulty, and anastomotic stricture.
aNumber of comparisons.
bHigh quality NRS (≥7 scores).
Meta-regression analysis of the high quality NRS.
| Operative time | ||||
| Year of publication | 32.400 | 12.368 | 3.154 to 61.646 | |
| Study type | 15.811 | 13.661 | 0.285 | −16.493 to 48.115 |
| procedure | 15.549 | 10.363 | 0.177 | −8.955 to 40.052 |
| Country of patients | 16.004 | 22.112 | 0.493 | −36.282 to 68.290 |
| Postoperative hospital stay | ||||
| Year of publication | 3.649 | 2.745 | 0.241 | −3.406 to 10.705 |
| Study type | 1.583 | 2.052 | 0.475 | −3.692 to 6.857 |
| procedure | 2.534 | 1.699 | 0.196 | −1.832 to 6.901 |
| Country of patients | 4.406 | 4.000 | 0.321 | −5.878 to 14.689 |
| Postoperaticve complications | ||||
| Year of publication | 1.367 | 0.382 | 0.487 to 2.248 | |
| Study type | 0.523 | 0.552 | 0.371 | −0.750 to 1.796 |
| procedure | 0.842 | 0.342 | 0.054 to 1.630 | |
| Country of patients | 0.510 | 0.382 | 0.500 | −1.157 to 2.177 |
NRS, non-randomized studies; Data in bold, significant P-value.
Subgroup-analyses of the high quality NRS by study quality, publish year, study type and type of the procedures.
| Items | na | RR or WMD 95% CI | ||||
|---|---|---|---|---|---|---|
| Before 2004 | 6 | 23.34 (10.97, 35.72) | 3.70 | 96.0% | ||
| After 2004 | 6 | −0.62 (−9.54, 8.30) | 0.14 | 0.892 | 93.9% | |
| Prospective cohort study | 6 | 13.03 (−3.00, 29.06) | 1.59 | 0.111 | 97.5% | |
| Retrospective cohort study | 6 | 10.17 (−2.37, 22.72) | 1.59 | 0.112 | 97.1% | |
| Omental patch repair | 4 | 11.42 (−15.12, 37.96) | 0.84 | 0.399 | 98.9% | |
| European patients | 10 | 14.23 (3.88, 24.58) | 2.70 | 96.6% | ||
| Asian patients | 2 | 0.10 (−31.50, 31.71) | 0.01 | 0.995 | 99.2% | |
| Before 2004 | 7 | −2.09 (−3.73, −0.44) | 1.56 | 92.8% | ||
| After 2004 | 3 | −3.75 (−4.89, −2.61) | 6.44 | 76.9% | ||
| Prospective cohort study | 4 | −2.52 (−4.65, −0.41) | 2.33 | 95.4% | ||
| Retrospective cohort study | 6 | −2.84 (−4.35, −1.33) | 3.68 | 90.3% | ||
| Omental patch repair | 4 | −3.08 (−5.47, −0.68) | 2.52 | 81.8% | ||
| European patients | 8 | −2.69 (−3.84, −1.55) | 4.62 | 94.2% | ||
| Asian patients | 2 | −3.18 (−7.08, 0.72) | 1.60 | 0.110 | 81.9% | |
| Before 2004 | 4 | −0.94 (−2.10, 0.22) | 1.59 | 0.112 | 90.8% | |
| After 2004 | 2 | −1.75 (−3.22, −0.28) | 2.33 | 98.9% | ||
| Prospective cohort study | 3 | −0.24 (−2.93, 2.45) | 0.18 | 0.860 | 87.4% | |
| Retrospective cohort study | 3 | −1.50 (−2.47, −0.53) | 3.03 | 98.2% | ||
| Omental patch repair | 2 | 0.55 (−5.32, 6.42) | 0.18 | 0.854 | 93.1% | |
| European patients | 6 | −1.34 (−2.12, −0.55) | 3.34 | 96.3% | ||
| Asian patients | 1 | / | / | / | / | / |
| Before 2004 | 3 | 3.08 (0.62, 15.36) | 1.37 | 0.170 | <0.1% | 0.966 |
| After 2004 | 2 | 0.28 (0.08, 0.99) | 1.98 | <0.1% | 0.730 | |
| Prospective cohort study | 1 | / | / | / | / | / |
| Retrospective cohort study | 4 | 0.61 (0.25, 1.51) | 1.06 | 0.289 | 38.1% | 0.183 |
| Omental patch repair | 2 | 0.49 (0.10, 2.27) | 0.92 | 0.359 | 38.1% | 0.204 |
| European patients | 4 | 0.94 (0.36, 2.47) | 0.12 | 0.901 | 24.7% | 0.263 |
| Asian patients | 1 | / | / | / | / | / |
| Before 2004 | 6 | 1.03 (0.64, 1.65) | 0.10 | 0.918 | 18.7% | 0.292 |
| After 2004 | 7 | 0.24 (0.12, 0.51) | 3.73 | 59.6% | ||
| Prospective cohort study | 5 | 0.65 (0.35, 1.18) | 1.43 | 0.154 | 31.5% | 0.211 |
| Retrospective cohort study | 8 | 0.39 (0.18, 0.86) | 2.33 | 75.9% | ||
| Omental patch repair | 4 | 0.43 (0.15, 1.21) | 1.60 | 0.110 | 66.6% | |
| European patients | 11 | 0.58 (0.32, 1.05) | 1.79 | 0.073 | 57.4% | |
| Asian patients | 2 | 0.18 (0.10, 0.33) | 5.55 | 14.1% | 0.281 | |
| Before 2004 | 7 | 0.74 (0.39, 1.43) | 0.89 | 0.375 | <0.1% | 0.657 |
| After 2004 | 5 | 0.56 (0.31, 1.00) | 1.96 | 0.050 | <0.1% | 0.803 |
| Prospective cohort study | 5 | 0.71 (0.37, 1.40) | 0.99 | 0.325 | <0.1% | 0.905 |
| Retrospective cohort study | 7 | 0.58 (0.32, 1.03) | 1.86 | 0.062 | <0.1% | 0.495 |
| Omental patch repair | 4 | 0.62 (0.20, 1.96) | 0.81 | 0.416 | <0.1% | 0.806 |
| European patients | 10 | 0.65 (0.42, 1.03) | 1.83 | 0.067 | <0.1% | 0.743 |
| Asian patients | 2 | 0.43 (0.09, 2.15) | 1.02 | 0.306 | <0.1% | 0.644 |
CI, confidence interval; RR, relative risks; WMD, weighed mean difference; data in bold, significant P-value.
aNumber of comparisons.
Figure 3Funnel plots of each outcome.
(A) operative time; (B) first oral intake; (C) postoperative hospital stay; (D) reoperation rate; (E) postoperative complications; (F) hospital mortality.
GRADE profile evidence of the included studies.
| Items | na | Type | Risk of bias | Quality assessment | No. of patients | Effect | Quality | Importance | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inconsistency | Indirectness | Imprecision | Other considerations | LR | OR | Relative 95% CI | Absolute | ||||||
| Operative time | 12 | NRS | No Serious | Serious | No serious indirectness | No serious imprecision | None | 393 | 496 | — | WMD 11.77 higher (1.75 to 21.79 higher) | ≈OOO Very low | Important |
| 3 | RCT | No Serious | Serious | No serious indirectness | Serious | None | 144 | 137 | — | WMD 7.61 higher (11.93 lower to 27.15 higher) | ≈≈OO Low | Important | |
| First oral intake | 6 | NRS | No Serious | Serious | No serious indirectness | No serious imprecision | None | 169 | 231 | — | WMD 1.34 lower (2.12 to 0.55 lower) | ≈OOO Very low | Important |
| 2 | RCT | No Serious | No serious inconsistency | No serious indirectness | Serious | None | 87 | 79 | — | WMD 0.27 lower (1.51 lower to 0.97 higher) | ≈≈≈O Moderate | Important | |
| Postoperative hospitalization | 10 | NRS | No Serious | Serious | No serious indirectness | No serious imprecision | None | 305 | 339 | — | WMD 2.38 lower (3.86 to 1.80 lower) | ≈OOO Very low | Important |
| 3 | RCT | No Serious | Serious | No serious indirectness | Serious | None | 144 | 137 | — | WMD 2.36 lower (6.47 lower to 1.74 higher) | ≈≈OO Low | Important | |
| Reoperative rate | 5 | NRS | No Serious | No serious inconsistency | No serious indirectness | Serious | None | 7/226 (3.1%) | 10/214 (4.7%) | RR 0.70 (0.30, 1.64) | 14 fewer per 1000 (from 33 fewer to 30 more) | ≈OOO Very low | Important |
| 2 | RCT | No Serious | No serious inconsistency | No serious indirectness | Serious | None | 5/87 (5.7%) | 2/79 (2.5%) | RR 2.11 (0.50, 8.97) | 28 more per 1000 (from 13 fewer to 202 more) | ≈≈≈O Moderate | Important | |
| Postoperative complications | 13 | NRS | No Serious | Serious | No serious indirectness | No serious imprecision | Strong association | 51/418 (12.2%) | 144/319 (42.5%) | RR 0.49 (0.27 to 0.88) | 217 fewer per 1000 (from 51 fewer to 310 fewer) | ≈≈OO Low | Critical |
| 4 | RCT | No Serious | No serious inconsistency | No serious indirectness | No serious imprecision | Strong association | 44/196 (22.4%) | 88/186 (47.3%) | RR 0.48 (0.36 to 0.65) | 246 fewer per 1000 (from 166 fewer to 303 fewer) | ≈≈≈≈ High | Critical | |
| Hospital mortality | 15 | NRS | No Serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 25/489 (5.1%) | 63/588 (10.7%) | RR 0.63 (0.41 to 0.98) | 40 fewer per 1000 (from 2 fewer to 63 fewer) | ≈≈OO Low | Critical |
| 3 | RCT | No Serious | No serious inconsistency | No serious indirectness | Serious | None | 3/139 (2.2%) | 8/128 (6.3%) | RR 0.39 (0.17 to 1.32) | 38 fewer per 1000 (from 52 fewer to 20 more) | ≈≈≈O Moderate | Critical | |
| Analgesic injection (days) | 3 | NRS | No Serious | Serious | No serious indirectness | Serious | None | 149 | 104 | — | WMD 3.60 lower (5.50 to 1.70 lower) | ≈OOO Very low | Important |
| 3 | RCT | No Serious | Serious | No serious indirectness | Serious | None | 139 | 128 | — | WMD 2.74 lower (5.62 lower to 0.15 higher) | ≈≈OO Low | Important | |
| Analgesic injection (mg) | 3 | NRS | No Serious | No serious inconsistency | No serious indirectness | Serious | None | 52 | 116 | — | WMD 106.59 lower(124.01 to 89.17 lower) | ≈OOO Very low | Important |
NRS, non-randomized studies; RCT, randomzed controlled trails; LR, laparoscopic repair; OR, open repair; RR, relative risks; CI, confidence interval.
aNumber of comparisons.
bHigh quality NRS (≥7 scores).
1High heterogeneity.
2Few events.
3Events present wild confidence intervals.
4Large magnitude of effect (RR <0.5 with no plausible confounders).